ABG Sundal Collier acted as Joint Bookrunner in the SEK 8.4 billion private placement and subsequent listing on Nasdaq First North Growth Market in Vimian

Vimian, a global, fast-growing and innovation-driven animal health business, offering products, services and solutions to veterinary professionals, labs and pet parents around the world, has successfully completed a private placement of existing and newly issued shares of SEK 8.4 billion and listing on Nasdaq First North Growth Market. Between 2015 and 2021, Vimian completed 24 acquisitions in 13 countries across Europe, North America and APAC within the group’s Specialty Pharma, Diagnostics, Veterinary Services and MedTech verticals.
The private placement comprised c. 110 million shares at a price of SEK 76 per share, corresponding to 28 per cent of the total number of shares in Vimian and a post-money equity valuation of c. SEK 29.6bn, and attracted significant cornerstone undertakings from SEB Investment Management, Swedbank Robur, Cliens, Handelsbanken Fonder, Danica Pension, BlackRock, I&T Asset Management, Keel Capital and Öresund. Trading commenced on 18 June 2021 under the ticker ‘VIMIAN’. ABG Sundal Collier acted as Joint Bookrunner in the transaction.